The MenC vaccine protects against meningococcal disease caused by Neisseria meningitidis group C bacteria. This disease is a major cause of meningitis.
What is Meningococcal Disease?
Meningococcal disease is a serious infection that can cause meningitis (inflammation of the protective membranes covering the brain and spinal cord) and septicaemia (blood poisoning). It's caused by bacteria called Neisseria meningitidis. Several types (serogroups) of this bacteria exist, with group C being one of the most common.
How Effective is the MenC Vaccine?
The MenC vaccine is highly effective, offering approximately 97% protection for babies within one year of vaccination. A second dose at 12 months is crucial for optimal protection.
Who Needs the MenC Vaccine?
Vaccination schedules vary by country and region. In the UK, for example, the MenC vaccine was part of the routine immunization schedule for many years (1999-2016). Currently, many countries include MenC vaccination as part of their childhood immunization programs, often combined with other vaccines like Hib (Haemophilus influenzae type b). Specific recommendations are available from your healthcare provider or local public health authorities. Some regions may offer a combined MenC/Hib vaccine.
Different Meningococcal Vaccines
It's important to note that MenC is just one type of meningococcal vaccine. Other vaccines, such as MenACWY (protecting against serogroups A, C, W, and Y), are also available. The MenB vaccine protects against a different serogroup. Your doctor can advise you on the most appropriate vaccine based on your needs and location.
